What You Should Know:
- In-depth look list of FDA-approved COVID-19 test kits
The U.S. Food and Drug Administration (FDA) offers emergency use authorizations (EUAs) for unapproved products or new uses for approved items in urgent situations where no suitable alternatives exist. Dozens of companies have sought and received EUAs for their testing kits that screen for SARS-CoV-2 — more commonly referred to as COVID-19 or the novel coronavirus.
The FDA makes a
Read More
genomics
Intel Launches $50M Pandemic Response Technology Initiative to Combat Coronavirus
What You Should Know:
- Intel pledges an additional $50 million in a pandemic response technology initiative to combat the coronavirus through accelerating access to technology at the point of patient care.
- Intel is committed to accelerating access to technology that can combat the current COVID-19 pandemic and enable new technology and the scientific discovery that better prepares society for future crises.
Intel is pledging an additional $50 million in a pandemic response
Read More
Analysis: Applying AI in the Fight Against The Coronavirus
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More
The Many Faces of AI in Clinical Trials
AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and discuss the impact on future clinical trial designs.
The
Read More
Life Image Launches Network Build to Help Providers Build Large-Scale Patient Data Networks
- Life Image launches Network Build Enterprise Solution to help healthcare organizations establish their own network connections to coordinate care and innovate. - Network Build allows healthcare organizations to create customized medical networks that can handle intensive data (e.g. diagnostic images, pathology, genomics, etc.) critical for advancing medical device development, clinical trials and more.Life Image, the world’s largest medical evidence network for clinical and imaging data,
Read More
Personal Genome Diagnostics, Mayo Clinic Partner to Enhance Patient Care in Oncology
- Together, PGDx and Mayo Clinic will focus on technology optimization and clinical utility studies for liquid biopsy and tissue-based genomic applications.- The shared vision and overall goal for PGDx and Mayo Clinic is to improve patient care by advancing the capabilities of oncology diagnostics testing. Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced a strategic collaboration with Mayo Clinic to enhance the development of clinical diagnostic solutions for
Read More
Health Data Privacy: Why Eroding Public Trust Harms Medical Research
Using Data Privacy to Empower Health Research
The importance of data security and data privacy policies have recently come under scrutiny due to revelations around Google’s Project Nightingale. The initiative with Ascension, the nation’s largest nonprofit health system, granted Google access to medical records of more than 50 million individuals in 21 states and may hinder the trajectory of health discovery by eroding “consumer” trust.
While historically it might have been a safe harbor to
Read More
7 Trends Impacting The Design of Healthcare Environments in 2020
SmithGroup one of the nation’s leading integrated design firms has tapped its broad network of 1,300 interdisciplinary design professionals to offer its predictions for the trends and challenges that the design industry will face in the decade ahead. Here are seven trends that are likely to impact the design of health care environments in the 2020s. 1. Adapting to the Climate Crisis“In the last couple of years, the impacts of climate change are increasingly viewed as a global crisis, and I
Read More
Executive Insights: Top Healthcare Predictions & Trends to Watch in 2020
As we close out the year, we asked several healthcare industry executives to share their predictions and trends for 2020.
Robbie Hughes, Founder, and CEO, Lumeon
“Following the announcement of the Trump administration's price transparency requirement – and the ensuing backlash from hospital groups – the issue of price transparency will dominate the healthcare industry next year. Regardless of the outcome of the lawsuit, I expect we'll see more attention around the importance of the
Read More
Paige Raises $45M to Expand AI-Native Digital Pathology Ecosystem to Accelerate Biomarker Discovery
- Paige raises $45M in Series B funding led by Healthcare Venture Partners with participation from Breyer Capital, Kenan Turnacioglu, and others. - The funding will be used to accelerate commercial efforts of its AI-native digital pathology ecosystem in the U.S., Europe, Brazil, and Canada. Paige, a NYC-based leader in computational pathology transforming the diagnosis and treatment of cancer, today announced it has closed its Series B funding round of $45 million, bringing the Company’s
Read More
